Many challenges exist when developing inhalation products, all of which are combination products. However, when you try to change an undesirable effect, systemic delivery of an active, into a feature there are additional hurdles that need to be considered. In addition, since the patient population and the health care professionals treating these non-pulmonary diseases are often not familiar with pulmonary devices, additional usability concerns arise. This talk will present some case studies that address these concerns.
Mick Hurrey, Vice President, Product Development, InCarda Therapeutics